Emergent BioSolutions signs contract modification award for CNJ-016
Source: SeekingAlpha
2025-07-08 17:25:19 ET
More on Emergent Biosolutions
- Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful
- Emergent BioSolutions Inc. 2025 Q1 - Results - Earnings Call Presentation
- Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript
- Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress
- Emergent Biosolutions Q1 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions signs contract modification award for CNJ-016
Adsouth Partners, Inc.
NASDAQ: ASPR
ASPR Trading
0.0% G/L:
$0.0006 Last:
1,966 Volume:
$0.0006 Open:
